Apyx Medical (NASDAQ:APYX) Trading 1.5% Higher – Should You Buy?

Apyx Medical Corporation (NASDAQ:APYX)’s stock price was up 1.5% during trading on Friday . The stock traded as high as $2.19 and last traded at $2.09. Approximately 36,763 shares traded hands during mid-day trading, a decline of 67% from the average daily volume of 110,911 shares. The stock had previously closed at $2.06.

Apyx Medical Price Performance

The company has a current ratio of 4.72, a quick ratio of 3.95 and a debt-to-equity ratio of 4.61. The stock has a market capitalization of $79.04 million, a PE ratio of -4.64 and a beta of 1.39. The firm has a 50 day moving average price of $2.12 and a 200 day moving average price of $1.58.

Apyx Medical (NASDAQ:APYX) last released its earnings results on Thursday, August 7th. The company reported ($0.09) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.09). Apyx Medical had a negative net margin of 37.11% and a negative return on equity of 158.22%. The company had revenue of $11.37 million for the quarter, compared to analysts’ expectations of $11.69 million. Apyx Medical has set its FY 2025 guidance at EPS. Research analysts anticipate that Apyx Medical Corporation will post -0.68 earnings per share for the current year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of APYX. Strategic Advisors LLC purchased a new position in shares of Apyx Medical during the 1st quarter valued at $27,000. Joel Isaacson & Co. LLC purchased a new position in Apyx Medical during the first quarter valued at $28,000. Fisher Asset Management LLC purchased a new position in Apyx Medical during the second quarter valued at $34,000. Citadel Advisors LLC grew its stake in Apyx Medical by 130.6% during the fourth quarter. Citadel Advisors LLC now owns 66,355 shares of the company’s stock valued at $105,000 after acquiring an additional 37,582 shares in the last quarter. Finally, Raymond James Financial Inc. purchased a new position in Apyx Medical during the fourth quarter valued at $134,000. Hedge funds and other institutional investors own 55.33% of the company’s stock.

Apyx Medical Company Profile

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.